Having worked at Boehringer Ingelheim for the past 13 years, Josh John is an integral part of the team, with experience working across the pharmaceutical company’s global portfolio products and in a range of departments, including global sourcing, market research, established brands marketing and peer-to-peer marketing.
Operating within such a large company brings unique opportunities — and challenges, including the politics and roadblocks that can get in the way of implementing new, disruptive technologies. Despite this, John remains unfazed. Case in point: In 2014, when virtual reality was still an emerging technology, he overcame internal obstacles to successfully launch a pilot virtual reality initiative.
The program was enough of a hit that John was able to expand it into a VR detail that could be leveraged by Boehringer Ingelheim’s field representatives. The program won the industry’s best sales aid at the PM360 Trailblazer Awards, as well as Gold honors from the PM360 PharmaChoice Awards.
Given these successes, it’s no surprise John is currently overseeing a growing range of virtual reality and augmented reality initiatives, using the technologies to deepen engagement and enhance storytelling to push the industry forward.
Part of this crusade includes giving talks at industry events, such as ePharma and Digital Pharma East, which incorporate his experiences pioneering new engagement tactics and strategies. John is also a frequent speaker at his alma mater, Sacred Heart University, where he gives regular lectures on real-world marketing and technology use cases.
From the May 01, 2020 Issue of MM+M - Medical Marketing and Media
